The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer

RNA Biology

Volumn 11, Issue 6, 2014, Pages

  Stockley, Jacqueline ^a   Villasevil, M Eugenia M ^a   Nixon, Colin ^b   Ahmad, Imran ^a   Leung, Hing Y ^a,b   Rajan, Prabhakar ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

3 UTR mRNA; CTNNB1; HNRNPA2B1; Prostate cancer; catenin

Indexed keywords

BETA CATENIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN 2; MESSENGER RNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HNRNP A2;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER GRADING; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLONY FORMING CELL; COLONY FORMING UNIT; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CONTROL; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LNCAP CELL LINE; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WILD TYPE; 3' UNTRANSLATED REGION; CELL TRANSFORMATION; CYTOPLASM; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; PROTEIN TRANSPORT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; MALE; NEOPLASM GRADING; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RNA, MESSENGER;

EID: 84906351344     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.28800     Document Type: Article

References (43)

1. Dreyfuss G, Matunis MJ, Piñol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993; 62:289-321; PMID:8352591; http://dx.doi.org/10.1146/annurev.bi.62.070193.001445
2. Han SP, Tang YH, Smith R. Functional diversity of the hnRNPs: past, present and perspectives. Biochem J 2010; 430:379-92; PMID:20795951; http://dx.doi.org/10.1042/BJ20100396
3. Liu Q, Dreyfuss G. In vivo and in vitro arginine methylation of RNA-binding proteins. Mol Cell Biol 1995; 15:2800-8; PMID:7739561
4. Nichols RC, Wang XW, Tang J, Hamilton BJ, High FA, Herschman HR, Rigby WF. The RGG domain in hnRNP A2 affects subcellular localization. Exp Cell Res 2000; 256:522-32; PMID:10772824; http://dx.doi.org/10.1006/excr.2000.4827
5. Chen ZY, Cai L, Zhu J, Chen M, Chen J, Li ZH, Liu XD, Wang SG, Bie P, Jiang P, et al. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Carcinogenesis 2011; 32:1419-26; PMID:21642356; http://dx.doi.org/10.1093/carcin/bgr088
6. Cui H, Wu F, Sun Y, Fan G, Wang Q. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma. BMC Cancer 2010; 10:356; PMID:20604928; http://dx.doi.org/10.1186/1471-2407-10-356
7. Golan-Gerstl R, Cohen M, Shilo A, Suh SS, Bakàcs A, Coppola L, Karni R. Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res 2011; 71:4464-72; PMID:21586613; http://dx.doi.org/10.1158/0008-5472.CAN-10-4410
8. Jing GJ, Xu DH, Shi SL, Li QF, Wang SY, Wu FY, Kong HY. Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma. J Gastroenterol Hepatol 2011; 26:108-15; PMID:21175803; http://dx.doi.org/10.1111/j.1440-1746.2010.06482.x
9. Zhou J, Allred DC, Avis I, Martínez A, Vos MD, Smith L, Treston AM, Mulshine JL. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 2001; 66:217-24; PMID:11510693; http://dx.doi.org/10.1023/A:1010631915831
10. Zhou J, Mulshine JL, Unsworth EJ, Scott FM, Avis IM, Vos MD, Treston AM. Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem 1996; 271:10760-6; PMID:8631886; http://dx.doi.org/10.1074/jbc.271.18.10760
11. David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010; 463:364-8; PMID:20010808; http://dx.doi.org/10.1038/nature08697
12. Moran-Jones K, Grindlay J, Jones M, Smith R, Norman JC. hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration. Cancer Res 2009; 69:9219-27; PMID:19934309; http://dx.doi.org/10. 1158/0008-5472.CAN-09-1852
13. Tauler J, Zudaire E, Liu H, Shih J, Mulshine JL. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res 2010; 70:7137-47; PMID:20807810; http://dx.doi.org/10.1158/0008-5472.CAN-10-0860
14. Huelga SC, Vu AQ, Arnold JD, Liang TY, Liu PP, Yan BY, Donohue JP, Shiue L, Hoon S, Brenner S, et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep 2012; 1:167-78; PMID:22574288; http://dx.doi.org/10.1016/j.celrep.2012.02.001
15. Rajan P, Elliott DJ, Robson CN, Leung HY. Alternative splicing and biological heterogeneity in prostate cancer. Nat Rev Urol 2009; 6:454-60; PMID:19657379; http://dx.doi.org/10.1038/nrurol.2009.125
16. Matlin AJ, Clark F, Smith CW. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 2005; 6:386-98; PMID:15956978; http://dx.doi.org/10.1038/nrm1645
17. Rajan P, Dalgliesh C, Bourgeois CF, Heiner M, Emami K, Clark EL, Bindereif A, Stevenin J, Robson CN, Leung HY, et al. Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies. BMC Cell Biol 2009; 10:82; PMID:19912651; http://dx.doi.org/10. 1186/1471-2121-10-82
18. Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, Leung HY, Elliott DJ. The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor. J Pathol 2008; 215:67-77; PMID:18273831; http://dx.doi.org/10.1002/path.2324
19. Busà R, Paronetto MP, Farini D, Pierantozzi E, Botti F, Angelini DF, Attisani F, Vespasiani G, Sette C. The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene 2007; 26:4372-82; PMID:17237817; http://dx.doi.org/10.1038/sj.onc.1210224
20. Hamilton BJ, Nichols RC, Tsukamoto H, Boado RJ, Pardridge WM, Rigby WF. hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun 1999; 261:646-51; PMID:10441480; http://dx.doi.org/10.1006/bbrc.1999.1040
21. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32:D277-80; PMID:14681412; http://dx.doi.org/10.1093/nar/gkh063
22. Kypta RM, Waxman J. Wnt/beta-catenin signalling in prostate cancer. Nat Rev Urol 2012; 8:418-28; PMID:22710668; http://doi:10.1038/nrurol.2012.116
23. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis 2013; 34:530-8; PMID:23188675; http://dx.doi.org/10.1093/carcin/ bgs371
24. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell 2012; 149:1192-205; PMID:22682243; http://dx.doi.org/10.1016/j.cell.2012.05.012
25. Bikkavilli RK, Malbon CC. Dishevelled-KSRP complex regulates Wnt signaling through post-transcriptional stabilization of beta-catenin mRNA. J Cell Sci 2010; 123:1352-62; PMID:20332102; http://dx.doi.org/10.1242/jcs.056176
26. Gherzi R, Trabucchi M, Ponassi M, Ruggiero T, Corte G, Moroni C, Chen CY, Khabar KS, Andersen JS, Briata P. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol 2006; 5:e5; PMID:17177604; http://dx.doi.org/10.1371/journal.pbio.0050005
27. Ruggiero T, Trabucchi M, Ponassi M, Corte G, Chen CY, al-Haj L, Khabar KS, Briata P, Gherzi R. Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling. BMC Mol Biol 2007; 8:28; PMID:17437629; http://dx.doi.org/10.1186/1471-2199-8-28
28. Yang G, Fu H, Zhang J, Lu X, Yu F, Jin L, Bai L, Huang B, Shen L, Feng Y, et al. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 2010; 138:231-40, e1-5; PMID:19686745; http://dx.doi.org/10.1053/j.gastro.2009.08.001
29. Fu Y, Huang B, Shi Z, Han J, Wang Y, Huangfu J, Wu W. SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis. EMBO Mol Med 2013; 5:737-50; PMID:23592547; http://dx.doi.org/10.1002/emmm.201202218
30. Spellman R, Llorian M, Smith CW. Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol Cell 2007; 27:420-34; PMID:17679092; http://dx.doi.org/10.1016/j.molcel. 2007.06.016
31. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature 2011; 473:337-42; PMID:21593866; http://dx.doi.org/10.1038/nature10098
32. Matoulkova E, Michalova E, Vojtesek B, Hrstka R. The role of the 3 2 untranslated region in posttranscriptional regulation of protein expression in mammalian cells. RNA Biol 2012; 9:563-76; PMID:22614827; http://dx.doi.org/10. 4161/rna.20231
33. Li J, Lu X. The emerging roles of 3′ untranslated regions in cancer. Cancer Lett 2013; 337:22-5; PMID:23726838; http://dx.doi.org/10.1016/j. canlet.2013.05.034
34. Ferron L, Davies A, Page KM, Cox DJ, Leroy J, Waithe D, Butcher AJ, Sellaturay P, Bolsover S, Pratt WS, et al. The stargazin-related protein gamma 7 interacts with the mRNA-binding protein heterogeneous nuclear ribonucleoprotein A2 and regulates the stability of specific mRNAs, including CaV2.2. J Neurosci 2008; 28:10604-17; PMID:18923037; http://dx.doi.org/10.1523/JNEUROSCI.2709-08. 2008
35. Katoh H, Mori Y, Kambara H, Abe T, Fukuhara T, Morita E, Moriishi K, Kamitani W, Matsuura Y. Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA. J Virol 2011; 85:10976-88; PMID:21865391; http://dx.doi.org/10.1128/JVI.00846-11
36. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996; 2:1627-36; PMID:9816342
37. Ahmad I, Patel R, Singh LB, Nixon C, Seywright M, Barnetson RJ, Brunton VG, Muller WJ, Edwards J, Sansom OJ, et al. HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer. Proc Natl Acad Sci U S A 2011; 108:16392-7; PMID:21930937; http://dx.doi.org/10.1073/pnas.1101263108
38. Kirkegaard T, Edwards J, Tovey S, McGlynn LM, Krishna SN, Mukherjee R, Tam L, Munro AF, Dunne B, Bartlett JM. Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 2006; 48:787-94; PMID:16722926; http://dx.doi.org/10.1111/j.1365-2559.2006.02412.x
39. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Köchli OR, Mross F, Dieterich H, Moch H, Mihatsch M, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001; 159:2249-56; PMID:11733374; http://dx.doi.org/10.1016/S0002-9440(10)63075-1
40. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, Taylor J. Galaxy: a web-based genome analysis tool for experimentalists. Current protocols in molecular biology / edited by Frederick M Ausubel [et al] 2010; Chapter 19:Unit 19 0 1-21.
41. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10:R25; PMID:19261174; http://dx.doi.org/10.1186/gb-2009-10-3-r25
42. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res 2002; 12:996-1006; PMID:12045153; http://dx.doi.org/10.1101/gr.229102. Article published online before print in May 2002
43. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 2013; 41:W77-83; PMID:23703215